Esin S, Salman M C, Ozyuncu O, Durukan T
Department of Obstetrics and Gynecology, Hacettepe University School of Medicine, Ankara, Turkey.
J Obstet Gynaecol. 2011 Oct;31(7):645-9. doi: 10.3109/01443615.2011.597461.
The objective of this study was to assess the impact of body mass index (BMI) on transobturator tape (TOT) success rates, patient acceptability and complications 1 year following surgery. The medical records of stress urinary incontinence (SUI) and mixed urinary incontinence (MUI) patients who underwent the TOT operation were retrospectively reviewed. The patients were divided into non-obese (BMI < 25) and obese (BMI ≥ 30) groups. Baseline and 1 year post-surgical outcomes were assessed by including multichannel urodynamics, Urogenital Distress Inventory (UDI-6) scores, Incontinence Impact Questionnaire (IIQ-7) scores and cure, failure and success rates. There were no significant differences between groups in terms of urodynamic parameters, objective cure rate and subjective success, quality of life scores, or postoperative complications. Both obese and non-obese patients had cure and/or improvement of their symptoms and had better quality-of-life in the postoperative period. As a conclusion, BMI does not affect the clinical effectiveness of TOT operation in the treatment of female SUI or MUI.
本研究的目的是评估体重指数(BMI)对经闭孔尿道中段无张力悬吊术(TOT)术后1年成功率、患者接受度及并发症的影响。对接受TOT手术的压力性尿失禁(SUI)和混合性尿失禁(MUI)患者的病历进行回顾性分析。将患者分为非肥胖组(BMI<25)和肥胖组(BMI≥30)。通过多通道尿动力学检查、泌尿生殖系统困扰量表(UDI-6)评分、尿失禁影响问卷(IIQ-7)评分以及治愈率、失败率和成功率来评估基线及术后1年的结果。两组在尿动力学参数、客观治愈率、主观成功率、生活质量评分或术后并发症方面均无显著差异。肥胖和非肥胖患者的症状均得到治愈和/或改善,且术后生活质量均有所提高。结论是,BMI不影响TOT手术治疗女性SUI或MUI的临床疗效。